Australia is carefully awaiting the arrival of retatrutide, a novel dual GIP and GLP-1 receptor agonist that's generating significant buzz in the global weight management landscape. Developed by Novo Nordisk, this https://blakennye418737.bluxeblog.com/75314482/this-new-drug-retatrutide-australia-a-new-hope-for-losing-weight